Oxazolidinone, either mononuclear or condensed with other heterocyclics, has established its importance in medicinal chemistry. A variety of biological activities have been reported by oxazolidinone derivatives. e present work describes the synthesis of several oxazolidinone derivatives, 3-(2-(7-chloroquinoline-4-ylamino)ethyl)-2-imino-5-(4-chloro/nitro/methoxy benzylidene)oxazolidin-4-one 4(a-c) and 4-(2-(7-chloroquinolin-4-ylamino)ethyl)-2(4-chloro/nitro/methoxy-benzylidene)-1,6-diox-4,9-di-azaspiro[4,4]nonane-3,8-dione 5(a-c). Synthesized compounds (1, 3, 4a, 5a, and 5c) were screened against bacterial strains such as S. aureus (MTCC 96) and E. coli (MTCC119) and fungal strains A. niger (MTCC 1344) and C. albicans (MTCC 871) compared with penicillin for bacteria and �uconazole for fungi as reference drugs by disk diffusion method. All synthesized compounds were identi�ed by the means of IR, NMR, and MS.
Introduction
Oxazolidinone derivatives showed very promising activities like monoamine oxidase A [1] , cancer [2] , HIV [3] and other interesting medicinal properties like aldose reductase inhibitors [4] , metabotropic [5] , and glutamate receptor antagonists [6] . e chemical literature is showed that chemistry and psychopharmacological properties of these materials have the great importance in medical chemistry, and this has led to an impressive armory of synthetic routes to be developed for these compounds which have resulted in the accumulation of an enormous volume of patented literature in the last decades [7] . In view of this fact, the compounds belonging to this class could be considered as interesting targets in the synthesis of compounds of medicinal interest [8] . On the other hand, it is well known that oxazolidinone derivatives have a great biological relevance; these compounds carry out diverse biological functions, being present in a number of biological systems involving several biochemist reactions of physiological relevance [9] [10] [11] . Although many methods for synthesizing oxazolidinone ring systems have been reported, they continue to receive a great deal of attention. Bacterial and fungal treatment has been a major endeavor of research and development in academic and pharmaceutical industry [12, 13] . Many of the available antimicrobial agents [14] exhibit undesirable side effects such as reduced bioavailability, toxicity [15] , and drug resistance [16, 17] . erefore, the search for novel and selective antimicrobial agents is urgently required due to problems associated with currently available antibacterial and fungal drugs.
Hence the signi�cant rising research interest in the design of oxazolidinones as drugs is currently observed in the �eld of pharmaceutical chemistry. Our present study focused on the synthesis and antimicrobial activities of novel oxazolidinones having quinoline ring.
Experimental
A chemicals were purchased from Aldrich Chemical Company (�SA) and used a�er puri�cation. e progress of reactions was checked by percolated aluminum silica gel 60F 254 thin layer plates. e NMR ( 1 H) spectra were recorded at 300 MHz. NMR spectra were obtained in solutions of CDCL 3 and chemical shis reported in parts per million (ppm) and TMS as an internal standard. Melting points were determined by open capillary and uncorrected. IR spectra were recorded on FT-IR Shimadzu 8400 Spectrophotometer and reported in wave numbers cm −1 . Column chromatography was performed on silica gel (Merck). Anhydrous sodium sulfate was used as drying agent for the organic phase.
General Method for the Preparation of N
1 -(7-Chloroquinoline-4-yl)ethane-1,2-diamine (1) . A mixture of 2.97 g (0.59 mol) 4,7-dichloroquinoline and 0.89 g (0.07 mole) 1-2-diaminoethane was dissolved in 30 mL of distilled ethanol in 250 mL round bottomed �ask and re�uxed for 8 h. e progress of the reaction was checked by TLC, and aer completion of the reaction, the mixture was cooled and the solvent was evaporated. e solid product obtained was extracted with DCM in presence of brine solution. Organic layer was separated and dried with Na 2 SO 4 . e solvent was evaporated under reduced pressure. e solid obtained was recrystallized from EtOH (Scheme 1).
General Method for the Preparation of 2-chloro-N (2-(7-Chloroquinoline-4-ylamino)ethyl) Acetamide (2).
A mixture of compound N-(7-chloroquinoline-4-yl)ethane-1,2-diamine (1) of 2.21 g (0.49 mmol) and chloroacetyl chloride of 0.75 mL (10 mmol) dissolved in triethyl amine (1 mL) and dry EtOH (25 mL) was stirred for about 30 min on ice bath then re�uxed for 4-6 hr. �rogress of the reaction was checked by TLC. Aer completion the reaction solution was cooled and the solvent was evaporated. e obtained solid product was separated with DCM and water mixture. e organic layer was �ltered and dried with Na 2 SO 4 . Resultant product was puri�ed by column chromatography in silica gel G (methanol and benzene). e eluate was concentrated, and the product was recrystallized from EtOH to give compound 2 (Scheme 1).
General Method for the Preparation of 3-(2-(7-Chloroquinoline-4-ylamino)ethyl)-2-iminooxazolid-4-one (3).
A mixture of compound (2) 2-chloro-N-(2-(7-chloroquinoline-4-ylamino)ethyl) acetamide of 1.38 g, (5 mmol) and potassium cyanate of 0.58 g (7 mmol) was dissolved in dry acetone (10 mL) and re�uxed on water bath for about 8 hr. e progress of the reaction was checked by TLC using methanol-benzene (1 : 9) ratio. Aer completion of the reaction, the reaction mixture was cooled and solvent was evaporated. e obtained solid product was neutralized by standard solution of NaHCO 3 and dried on Na 2 SO 4 (Scheme 1).
Yields 
General Method for the Preparation of 3-[(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-chlorobenzylidene)] Oxazolidin-4-one (4a).
A mixture of compound (3) 3-(2-(7-chloroquinoline-4-ylamino)ethyl)-2-imino-oxazolid-4-one of 0.30 gm (0.12 mmol), sodium acetate 0.10 gm, and p-chlorobenzaldehyde of 0.127 gm (0.171 mmol) was dissolved in dry benzene (20 mL). e reaction mixture was re�uxed on water bath for 8 hr at 80-100 ∘ C. e progress of the reaction was checked by TLC using methanolbenzene (1 : 9) ratio as an eluent. Aer completion of the reaction, the reaction mixture was cooled and solvent was evaporated. e obtained product was puri�ed by column chromatography and recrystallized with ethanol to give 3-[(2-(7-chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-chlorobenzylidene)] oxazolidin-4-one (Scheme 1).
General Method for the Preparation of 3-[(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-nitrobenzylidene)] Oxazolidin-4-one (4b).
A mixture of compound (3) 3-(2-(7-chloroquinoline-4-ylamino)ethyl)-2-imino-oxazolid-4-one of 0.30 gm (0.13 mmol), sodium acetate of 0.10 gm, and p-nitrobenzaldehyde of 0.37 gm (0.038 mmol) was dissolved in dry benzene (20 mL). e reaction mixture was re�uxed on water bath for 8 hr at 80-100 ∘ C. e progress of the reaction was checked by TLC using methanol-benzene (1 : 9) ratio as an eluent. Aer completion of the reaction, the reaction mixture was cooled and the solvent was evaporated. e obtained product was puri�ed by column chromatography and recrystallized with ethanol to give 3-[(2-(7-chloroquinolin-4-ylamino) ethyl-2-imino-5-(4-nitro benzylidene)] oxazolidin-4-one (Scheme 1).
General Method for the Preparation of 3-[(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-methoxybenzylidene)] Oxazolidin-4-one (4c).
A mixture of compound (3) 3-(2-(7-chloroquinoline-4-ylamino)ethyl)-2-iminooxazolid-4-one 0.30 gm (0.12 mmol), zinc chloride of 0.50 mg, and p-methoxybenzaldehyde of 0.127 gm (0.017 mmol) was dissolved in glacial acetic acid (20 mL). e reaction mixture was re�uxed on sand bath for 8 hr at 120 ∘ C. e progress of the reaction was checked by TLC using methanol-benzene (1 : 9) ratio as an eluent. Aer completion of the reaction, solution was cooled and neutralized with NaHCO 3 , to obtained white precipitated compound. e compound crystallized with methanol and water and recrystallized with ethanol to give 3-[(2-(7-chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-methoxybenzylidene)] oxazolidin-4-one (Scheme 1).
General Method for the Preparation of 4-(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-(4-chlorobenzylidene)-1,6-dioxa-4,9-diazaspiro[4,4]nonane-3,8-dione (5a).
A compound (4a) 3-(2-(7-chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-chlorobenzylidene) oxazolidin-4-one of 0.30 gm (0.12 mmol) and glycolic acid of 3.37 gm (0.25 mmol) was dissolved in dry benzene (20 mL) and re�uxed on water bath for about 24 hr. e progress of the reaction was checked by TLC using methanol-benzene (2 : 8) as an eluent. Aer completion of the reaction, it was cooled and neutralized with aqueous standard solution of sodium bicarbonate (NaHCO 3 ) and water successively and puri�ed by column chromatography to obtain 4-(2-(7-chloroquinolin-4-ylamino)ethyl)-2(4-chlorobenzylidene)-1,6-diox-4,9-diazaspiro [4, 4] 
General Method for the Preparation of 4-(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-(4-nitrobenzylidene)-1,6-dioxa-4,9-diazaspiro[4,4]nonane-3,8-dione (5b). A compound (4b)
3-(2-(7-chloroquinolin-4-ylamino)ethyl)-2-imino-5-(4-nitrobenzylidene) oxazolidin-4-one of 0.30 gm (0.12 mmol) and glycolic acid of 3.37 gm (0.25 mmol) was dissolved in dry benzene (20 mL) and re�uxed on water bath for about 24 hr. e progress of the reaction was checked by TLC using methanol-benzene (2 : 8) as an eluent. Aer completion of the reaction, it was cooled and neutralized with aqueous standard solution of sodium bicarbonate (NaHCO 3 ) and water successively and puri�ed by column chromatography to obtain 4-(2-(7-chloroquinolin-4-ylamino)ethyl)-2(4-nitro benzylidene)-1,6-diox-4,9-diazaspiro [4, 4] nonane-3,8-dione (Scheme 1).
General Method for the Preparation of 4-(2-(7-Chloroquinolin-4-ylamino)ethyl)-2-(4-methoxybenzylidene)-1,6-dioxa-4,9-diazaspiro[4,4]nonane-3,8-dione (5c).
A compound (4c) 3-(2-(7-chloroquinolin-4-ylamino)ethyl-2-imino-5-(4-methoxybenzylidene) oxazolidin-4-one of 0.30 gm (0.12 mmol), zinc chloride of 0.50 mg, and glycolic acid 3.37 gm (0.25 mmol) was dissolved in glacial acetic acid (20 mL) and re�uxed on sand bath for about 6-7 hr. e temperature of the reaction mixture was raised to 120 ∘ C and maintained at the same temperature. e progress of the reaction was checked by TLC using methanol-benzene (2 : 8) as an eluent. Aer completion of the reaction, it was cooled and neutralized with ammonium hydroxide and puri�ed by column chromatography to obtain 4-(2-(7-chloroquinolin-4-ylamino)ethyl)-2(4-methoxy-benzylidene)-1,6-diox-4,9-diazaspiro [4, 4] 
Results and Discussion
e key intermediate 1 was prepared by nucleophilic reaction involving 4,7-dichloroquinoline and 1,2-diaminoethane in the presence of ethanol. N 1 -(7-Chloroquinoline-4-yl)ethane-1,2-diamine (1) reacted with chloroacetyl chloride and give 2-chloro-N (2-7-Chloroquinoline-4-ylamino)ethyl) Acetamide (2). Imino-oxazolidi-4-one derivatives (3) was obtained from acetamide (chloroacetanilide) derivatives, by nucleophilic attack of cyanate functional group of potassium cyanate followed by cyclization in dry acetone medium. Imino-5-(4-substituted benzylidene) oxazolidin-4-one derivatives (4a-c) were obtained by the re�uxing of substituted aldehydes paracholoro, paranitro, and paramethoxy benzaldehydes with imino oxazolidinone derivatives (3) to generate 4(a-c). Spiro-oxazolidinone derivatives 5(a-c) were obtained by the reaction of imino-5-(4-substituted benzylidene) oxazolidin-4-one derivatives 4(a-c) with glycolic acid in dry benzene medium. e synthetic route of the compounds is outlined in Scheme 1. e newly synthesized compounds were characterized by FT-IR, NMR (1H) and mass spectral data.
Antimicrobial Activity
Five of the newly synthesized compounds were evaluated for their in vitro antibacterial activity against S. aureus (MTCC 96) and E. coli (MTCC119) and antifungal activity against A. niger (MTCC 1344) and C. albicans (MTCC 871) organisms. Disk diffusion method was used for the determination of the preliminary antibacterial and antifungal activities. Penicillin for bacteria and �uconazole for fungi were used as reference drugs. e results depicted in Tables 1 and 2 revealed that most of the tested compounds displayed variable inhibitory effects on the growth of the tested organisms. Regarding the activity of the oxazolidinone derivatives against bacteria, the results revealed that compounds 5c and 4a exhibited broad spectrum of antibacterial pro�les against the tested organisms. Regarding the activity of oxazolidinones derivative against antifungal strains the results revealed that compounds 5a and 5c revealed strong growth inhibition against the tested fungi.
Conclusion
In conclusion, the objective of the present study was to synthesize and investigate the antimicrobial activities of some new heterocyclic oxazolidinone derivatives. Our aim was to synthesize the compounds by the incorporating oxazolidinones and quinoline nucleus with substituted benzaldehyde into one molecular framework which is view to examine change if any. if such an association could produce a favorable impact on the biological properties in the newer synthetic materials. e obtained results clearly revealed that some of the newly synthesized compounds exhibited better anti microbial activity
